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Objective. To compare the anthropometric 
characteristics of children with and without 
HIV-1 infection. 
Methods. In a prospective cohort study of 218 
children born to HIV-1 seropositive mothers and 
218 children born to HIV-1 seronegative mothers 
in Kigali, Rwanda, 3 groups were compared: in- 
fected children (n = 46); uninfected children 
born to seropositive mothers (n = 140); and un- 
infected children born to seronegative mothers 
(n  = 207). Weight, height and head circumference 
were measured at  birth, every 3 months during 
the first year of life and every 6 months thereaf- 
ter. The weight-for-age, height-for-age, weight- 
for-height and head circumference-for-age mean 
z scores were calculated. 
Results. The weight-for-age, height-for-age and 
head circumference-for-age mean z scores were, 
lower among HIV-infected children than among 
uninfected ones at each time period. The reduc- 
tion in the weight-for-age mean z score was the 
greatest between 12 and 36,months. The reduc- 
tion in the height-for-age mean z score of HIV- 
infected children was persistently below 2 SD 
after 9 months of age. On the other hand the 
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weight-for-height mean z score was not consis- 
tently lower in HIV-infected children when com- 
pared with uninfected ones. The anthropometric 
characteristics of uninfected children born to 
seropositive mothers were similar to those of 
children born to seronegative mothers. 
Conclusions. In  this study HIV-infected chil- 
dren were more frequently stunted (low height- 
for-age) than uninfected ones. Wasting (low 
weight-for-height) was not common among HIV- 
infected children. 
INTRODUCTION . 
Since the first descriptions of pediatric AIDS a de- 
cade a large body of information has accumu- 
lated on the mother to  child transmission of HIV type 1, 
its natural history and the clinical expression of HIV 
infection in ~hildren.~-ll However, few data are avail- 
able on the anthropometric characteristics of HIV- 
infected children,12-15 particularly in sub-Saharan Af- 
rica where the majority of pediatric AIDS cases occur. 
From 1988 to  1994 a prospective cohort study on the 
perinatal transmission of HIV has been performed in 
Kigali, the capital of We report on the 
anthropometric findings collected during the first 4 
years of life on children born to  HIV-infected and 
uninfected mothers. 
METHODS 
Details about enrollment and follow-up procedures 
in the cohort have been described elsewhere.16 Briefly 
218 infants born to 215 HIV-seropositive mothers were 
enrolled at birth between November, 1988, and June, 
1989, at the maternity ward of the Centre Hospitalier 
de Kigali. These children were matched with 218 
children born to  HIV-seronegative mother 
The children and their mothers were 
age and parity. i 
2 weeks during the first 2 years of follow-up and-every 
479 
480 
4 weeks thereafter. They were either visited at home by 
a social worker or attended the outpatient clinic orga- 
nized within the Mother and Child Health Clinic of the 
Centre Hospitalier de Kigali. In addition the children 
were systematically examined by a physician every 3 
months during the first year of life and eveiy 6 months 
thereafter. When necessary children were seen in the 
outpatient department or hospitalized in the Depart- 
ment of Pediatrics and treated free of charge. All the 
children were immunized during the first 15 months of 
life following the recommendations of the World Health 
Organization Expanded Programme of Immunization 
with one exception; a high dose Edmonston-Zagreb 
measles vaccine was given at 6 months of age in the 
place of the Schwarz vaccine at 9 months.1' The phy- 
workers were blinded to the HN 
infection status of the children to 18 months of age. 
Definitions of pediatric HW infection and c.as- 
sification of the children. Criteria used to  define 
children born to seropositive mothers as infected with 
HIV, uninfected or with an indeterminate status were 
drawn from a Working Group Consensus on Mother- 
to-Child Transmission of HN-L8 This classification 
takes into account the HIV antibody serostatus at 15 
months of age and, when the child died before this age, 
the presence or absence of signs and symptoms possibly 
related either (1) in a child fulfilling the WHO clinical 
case definition of pediatric AIDS (in which severe 
and/or recurrent pulmonary infection was considered 
sign)lg9 2o or (2) in a child with at least one HIV-related 
infection or persistent diarrhea (214 days) beyond the 
were regarded as HIV-related: persistent diarrhea; 
failure to  thrive (< 80% weight for age); generalized 
'wphadenopathy (lymph nodes measuring at least 
cm and present in two or more extrainguinal sites); oral 
candidiasis (beyond the neonatal period); severe or 
recurrent Pneumonia; Chronic Parotitis and herpes 
zoster infection (shingles). 
The children born to HIV-seropositive mothers were 
considered as HN-infected (Group 1) (1) if they pre- 
sented clinical manifestations of AIDS at any time 
during the follow-up, (2) if they were positive for HIV 
antibody at 15 months of age or (3) if they died before 
15 months of age and their death was considered 
HIV-related. They were considered as HIV-uninfected 
Ôr seroreqeders (Group 2) if (1) they were negative for 
ibOdY at 15 months or (2) if they died before 
, they were HIV-seronegative and their death 
robably undated to HIV. Children born to HIV- 
e mothers who were lost to follow-up before 
of age were considered uninfected when the 
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HIV antibody test was negative at 9 months of age or 
beyond. In all other circumstances the H N  infection 
status of children born to  HTV-seropositive women was 
considered indeterminate (Group 41.' 
The children born to HIV-seronegative mothers 
(Group 3) were retested for HIV antibody every 3 
months. Nine of them who became HIV seropositive 
before the age of 24 m ~ - ~ t h s ~ ~  together with their 
mothers were exChded from the analysis after the 
presumed time of seroconversion. 
Serologic methods. At delivery and at 3-month 
intervals thereafter, the child and mother's sera were 
tested for HN-1 antibodies by a COIm."Cial enzyme- 
linked immunosorbent assay (Em, Vironostika@; Or- 
ganon Teknika, Boxtel, the Netherlands). Samples that 
tested positive were further confirmed by a commercial 
Western blot technique (Du Pont, Wilmington, DE) 
with the Centers for Disease Control criteria of inter- 
pretationF2 
Anthropometric measurements. Weights, 
heights and head circumferences were obtained at 
birth and at 3-month intervals thereafter. Naked chil- 
dren were weighed on a mechanical scale (Seca@). 
Heights were obtained horizontally in a length- 
measuring box until 36 months of age and vertically 
thereafter. 
Statistics. Weight-for-age (W-A), height-for-age 
for-height (w-H) were calculated with the data 
from the National Center for Health Statistics as 
referencesF3,24 The (or sD score) for w-A, for 
weight of the reference population at the age 
weight of the reference at that age, Values 
Analysis of variance was used for comparison be- 
tween the Each time the p value 
reached the chosen level of significance (0.05), two 
group compa~sons ( G ~ ~ ~ ~  1 us. G~~ ~ 2, G~~~  1 us.
Group 3 and Group 2 us. Group 3) were performed and 
results were considered StatisticalIy significant at P = 
0.017, using the Bonferroni correction for multiple 
comparisons and taking into account the sample size of 
each group compared. 
RESULTS 
Among the 218 children born to HIV-seropositive 
mothers, 46 were classified as HIV-infected (Group 11, 
140 as uninfected (Group 2) and 32 as indeterminate 
for HIV infection (Group 4). Table 1 summarizes the 
number of children alive at each time of nutritional 
assessment, the number of children with anthropomet- 
ric measurements performed and the number of chil- 
dren who died in the preceding period. 
The W-A, H-A and HC-A mean z scores were lower 
and 
f 
i 
to HIV infection* Death was defined as HIV- @-A), head circumference-for-age (HC-A) and weight- 
as a major si@ in the place of chronic cough as a minor instance, is calculated by subtracting the median 
sign/symptom when last Seen and dying from Severe from the weight and dividing by the SD of the 
first weeks of life* The following Sips and symptoms are reported under Results as mean z Score 2 SD. 
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TABLE 1. Summary of the first 4 years of follow-up and of anthropometric measurements performed i n  children born to 
HIV-positive and -negative mothers, Kigali (Rwanda), 1989 to 1993 
-3 - 
- 4 -  
-5 
Group 1. Uninfe'cted Uniif&ferctea 
HIV-1- children born children born Group 4. Examined/ Deaths in the Age (mo) 
1 I L I l l I l 
infected to to  Indeter&nate'@ alive preceding period 
children seropositive seronegative 
mothers mothers 
3 46/46 (l00)t 
6 41/42 (98) 
9 37/39 (95) 
12 33/33 (100) 
18 22/25 (88) 
24 18/22 (82) 
30 16/18 (89) 
36 13/15 (87) 
42 13/14 (87) 
48 'a 10/14(71) 
140/140 (100) 
140/140 (100) 
140/140 (100) 
13'71139 (99) 
126/137 (92) 
117/130 (90) 
112/127 (88) 
101/112 i901 
961112 (86) 
931107 (87) 
2071207 (100) 
196/204 (96) 
186/201 (93) 
182/199 (91) 
164/195 (84) 
156/189 (83) 
157/184 (85) 
146/170 (86) 
134158 (85) 
132/148 (89) 
~ 
21/21 (100) 414/414 (100) 
16/18 (89) 393/404 (97) 
3/11 (273 366/391(94) 
0/8 (O) 3521379 (93) 
312/357 (87) 
291/341(85) 
285/329 (87) 
260/297 (88) 
243/284 (86) 
2351269 (87) 
15 
6 
5 
10 
9 
5 
3 
1 
1 
1 
* See definitions under Methods. 
t Numbers in parentheses, percent 
throughout the entire follow-up period among HIV- 
infected children than among uninfected ones (Figs. 1 
to 3). The difference in the W-A and H-A mean z scores 
between Group 1 and Group 3 children was statisti- 
cally significant (P < 0.017) during the first 3 years of 
life (except àt 30 months of age for the W-A mean z 
score (Fig. 1) and except at 36 months of age for the 
H-A mean z score (Fig. 2)). The difference in the HC-A 
mean z scores between Group 1 and Group 3 children 
was statistically significant (P < 0.017) during the first 
2 years of life (except at birth, 12 and 18 months of age 
(Fig. 3)). The reduction in the W-A mean z score was 
z-score  
3 - G1 - G2 - G3 2 -  
1 -  
~~ 
Age O 3 6 9 12 18 24 30 36 42 48 
p-value 
G1 vs G2 0.003 10-5 10-5 10-5 10-3 10-3 10-3 0.05 10-3 0.20 ' - 
Gl YS G3 10-4 10-8 10-6 10-7 10-5 10-3 10-3 0.02 10-3 0.02 
. G2vsG3 0.20 0.06 0.02 0.14 0.11 0.30 0.90 0.50 0.50 0.10 
, . . .~ I.-. 
. . i  " ., , ..I . ,I  , I.., .-i ~ . .  .  , . .~ + _ . .  . 
, : 
. $4 
, -  
"i 
.i ;! 
i-.. . ., , ,.. . 
-3 y 
I i 
).a.) -. 
&' 
r 
< 
482 
2 -  
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m G1 - G2 
_Q_ G3 
z - s c o r e  
-5- I I I I 1 I I 1 
O ' 1  
Age O 3 6 Y 12 18 24 30 36 42 48 
p-value 
GI vs G2 0.04 0.02 0.01 0.01 0.02 o.oz 10-3 0.01 - 0.05 
G1 vs G3 c 10-3 10-3 10-5 10-3 0.01 0.01 10-3 0.01 - 0.02 *- - 
G2 vs G3 0.10 0.04 0.01 0.05 0.06 0.20 0.90 0.90 - 0.50 
Overall 10-4 10-3 10-4 10-4 < 10-3 0.006 0.002 0.02 0.28 0.04 0.13 
FIG. 2. Mean height-for-age z score in HIV-1-infected and uninfected children, Kigali (Rwanda), 1989 to 1993. G1, HIV-infected 
children; G2, uninfected children born to seropositive mothers; G3, uninfected children born to seronegative mothers. 
already noticeable at 3 months of age but was the 
greatest (below 2 SD) between 12 and 36 months of age 
(Fig. 1). The reduction in the H-A mean z score of 
HIV-infected children was also manifest at 3 months of 
age, with a decrease below 2 SD from 9 to 48 months of 
age (Fig. 2). Moreover the HC-A mean z score of 
HIV-infected children was below 1 SDSD from 18 to 36 
months of age (Fig. 3). 
On the other hand the W-H mean z score was rarely 
lower in HIT-infected children than in uninfected ones, 
the difference being only statistically significant (P < 
0.017 for Group 1 us. Group 3) at ages 3, 6,24 and 36 
months (Fig. 4). The W-H mean z score of HIV-infected 
children was not frequently impaired according to 
international standards. 
Although often low in comparison to  international 
standards, the W-A, H-A and HC-A mean z scores of 
HIV-uninfected- children born to seropositive (Group 2) 
and those born to seronegative mothers (Group 3) were 
comparable (Figs. 1 to 3). Indeed statistically signifi- 
cant differences for W-A, H-A and HC-A mean z scores 
(P < 0.017 for Group 2 us. Group 3) were not observed 
during the first 48 months of life between these two 
groups except at 6 months of age for the H-A mean z 
score (Fig. 2). 
h m g  the HIV-infected children who survived until 
48 months of age, there was a decline of the W-A mean 
z score until 36 months of age (at 12 months, -1.53 t 
1.11; at 24 months, -1.90 t 1.63; at 36 months, -2.31 
t 0.98) with a stabilization in the growth parameters 
thereafter. At 12 months of age the anthropometric 
characteristics of the HIV-1-infected children who sur- 
vived this second year of life were better than those of 
infected children who died between 12 and 24 months: 
W-A mean z score of survivors (n = 21), -1.84 t 1.42 
us. -3.05 t 1.10 among those who died (n = 12) (P = 
0.009); H-A meanz score of survivors, -2.12 t 0.86 us. 
-3.22 2 1.85 among those who died (P = 0.03). 
DISCUSSION 
Studies from Africa25i 26 have previously shown that 
the mean birth weight and the mean birth length of 
HIV-infected children :was lower than among unin- 
fected newborns of HIV-seronegative mothers. In the 
United States McKinney et als1' have retrospectively 
analyzed the growth of children born to seropositive 
4.' 
Vol. 15, No. 6, June, 1996 THE PEDIATRIC INFECTIOUS DISEASE JOURNAL 483 
2 -  
m G1 - G2 
G3 
-., 4 
-5 I I l I 1 I I 1 . '  1 
O 6 12 18 24 30 36 42 48 
Age (months) 
Age O 3 6 9 12 18 24 30 36 
D-value 
G1 vs G2 0.01 10-3 0.01 0.01 0.01 0.01 - 
G1 vs G3 10-3 10-3 0.01 0.05 0.01 0.05 - 
G2 vs G3 0.34 0.81 0.99 0.30 0.50 0.10 - 
Overall 0.26 0.003 <lo-3 0.002 0.07 0.006 0.02 0.01 0.07 
FIG. 3. Mean head circumference-for-age z score in HIV-l-infected and uninfected children, Kigali (Rwanda), 1989 to 1993. GI, 
HIV-infected children; G2, uninfected children born to seropositive mothers; G3, uninfected children born to seronegative mothers. 
mothers and observed diminished stature and weight 
gain in HIV-infected children when they were com- 
pared to seroreverters. However, two-thirds of the 
HIV-infected children included in their study were 
referred for antiretroviral therapy after 3 months of 
age; therefore the design of this study was not optimal 
to  evaluate the general impact of HIV on the nutri- 
tional status of young HIV-infected children. In the 
European Collaborative Study15 HN-infected children 
were shorter and weighed less than their uninfected 
counterparts. Although statistically significant, the dif- 
ference between infected and uninfected children was 
small in this study.15 Until now follow-up studies of 
anthropometric measurements of African HIV-infected 
children were lacking. 
Our prospective cohort study of Rwandan children 
born to  HIV-infected and uninfected mothers followed 
from birth until 48 months of age demonstrates an 
early, severe and sustained impairment in weight, 
height and head circumference gain among HIV- 
infected children when compared with uninfected ones 
of the same age, birth order and socioeconomic status. 
None of these African HIV-infected children received 
zidovudine. Indeed antiretroviral treatment has a pos- 
itive impact on weight growth  rate^.'^ On the other 
hand the W-H mean z scores of HN-infected children 
from this study were generally comparable to  the 
figures obtained with uninfected ones or to interna- 
tional standards. The same findings were observed in 
North American children'' as well as among perina- 
tally HIV-l-infected school age children in Rwanda.28 
A cross-sectional study of malnourished children with 
an HIV-1 seroprevalence of 14% in Butare, Rwanda, 
also showed that seropositivity was found more fre- 
quently among children with low W-A and H-A than 
among those with low W-H.29 The pathogenesis of 
malnutrition in HIV-1 infection is poorly understood 
and the respective roles of infections, endocrinologic 
dysfunctions and the possibility of an increased resting 
energy expenditure in infected patients remain to  be 
delineated?8s 30-32 In this study low W-A and low H-A 
occurred only in HIV-l-idected children with a history 
of severe á d o r  persistent infectious illnesses such as 
persistent diarrhea, chronic fever and pneumonia (data 
not shown), strongly suggesting that infections were an 
important cause of poorer growth in these infected 
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- 2 -  
-3 - 
-4- 
-5 
z-score 
3 1 
I I I I I 1 I I 
2 -1 I II) G1 , - G2 
1 IZI- G3 
a n 
Age O 3 6 9 12 18 24 30 36 42 48 
I 
p-value 
G1 vs G 2  - 10-3 0.02 0.01 - 0.01 - - 
G1 vs G3 10-3 0.01 0.01 - 0.01 - 
G2 vs G3 0.58 0.55 0.90 - 0.20 - 
Overall 0.06 <10-3 0.02 0.50 0.50 0.27 0.004 0.20 0.003 0.15 0.27 
FIGURE 4. Mean weight-for-height z score in HIV-1-infected and uninfected children, Kigali (Rwanda), 1989 to 1993. GI, HN-infected 
children; G2, uninfected children born to seropositive mothers; G3, uninfected children born to seronegative mothers, 
children. Larger numbers of HIV-1-infected children 
are needed to confirm the stabilization of the growth 
measurements observed between 24 and 48 months of 
age in this study. Moreover, more detailed nutritional 
studies should be undertaken to determine the mech- 
anisms of malnutrition in these HIV-1-infected chil- 
dren. 
Until 36 months of age the HC-A mean z scores of the 
HIV-1-infected children were lower than those of unin- 
fected ones in this study. This is consistent with the 
demonstrated neurotropic characteristics of HIV-l.33 
HIV-infected children from this cohort have previously 
been shown to be more frequently developmentally 
delayed than HIV-uninfected children during the first 
2 years of life, although no case of encephalopathy has 
been observed during this period.34 
This study emphasizes the importance of the com- 
parison groups of uninfected children of the same 
socioeconomic, .obstetrical and genetic background for 
the interpretátion of anthropometric indices and their 
evolution over time. In this study uninfected children 
born to seropositive mothers had the same W-A, H-A 
and HC-A mean z scores than those born to seronega- 
tive mothers. We have already shown that uninfected 
children born to seropositive mothers had the same 
neonatal characteristics and the same neurodevelop- 
mental testing than those born to  seronegative moth- 
e r ~ . ~ ~ ’ ~ ~  In contrast we have now demonstrated that 
these uninfected children are frequently thin and small 
in comparison to  international standards. 
In conclusion this study shows that Rwandan HIV- 
1-infected children ages O to  48 months old are fre- 
quently undernourished (low W-A) and stunted (low 
H-A), but not wasted (low W-HI, compared with unin- 
fected children. Uninfected children born to  HIV-1- 
seropositive mothers and those born to seronegative 
mothers have the same anthropometric characteristics. 
Recent cro~s-sectional~~ and 10ngitudinal~~ data from 
Zaire have shown that diarrhea was strongly associ- 
ated with severe malnutrition and HIV-1 infection. 
Therefore it remains to  be demonstrated whether early 
nutritional interventions in those children with stunt- 
ing and low W-A have an impact on the survival of 
African HIV-1-infected children. 
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